Speaker
Chief Executive Officer, Shaperon
Shawn Seong, Chief Executive Officer at Shaperon, is speaking at World CNS Summit South Korea (Incheon, South Korea, 9–10 Dec 2026) in the session “Advancing GPCR19 Positive Allosteric Modulation: Phase I Data From NuCerin, a First-in-Class Therapy for Alzheimer’s Disease”.
9–10 Dec 2026Incheon, South Korea
Head of Neuroscience, ABL Bio Inc.
Senior Scientist, JCR Pharmaceuticals Co Ltd
Senior Vice President, AriBio
Executive Director, AUTOTAC Bio
Chief Scientific Officer, Angelini Pharma Inc
Chief Scientific Officer, Zincure
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Shawn Seong, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].